Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma

In conclusion, DCs may contribute to the disturbed immunological interplay typical of cHL, prompting a further evaluation of their value as a potential new biomarker.

Source: British Journal of Haematology - November 13, 2018 Category: Hematology Authors: Domenico Galati, Serena Zanotta, Gaetano Corazzelli, Dario Bruzzese, Gaetana Capobianco, Emanuela Morelli, Manuela Arcamone, Rosaria De Filippi, Antonio Pinto Tags: Research Paper Source Type: research